David Curtis Glebe, a retired 64-year-old public prosecutor now living in Millsboro, Delaware, knows he’s lucky to be alive. In mid-2013, while in Arizona, Glebe was diagnosed with pancreatic neuroendocrine cancer (PNET) — the same disease that killed Apple’s founder and CEO Steve Jobs. After three years of progress…
News
Using rapamycin to rein in an overactive mTOR cell signaling pathway isn’t an effective way to treat fragile X syndrome, a study in mice indicates. It showed that rapamycin does not reverse most behavioral characteristics of the disease, including learning and memory problems, susceptibility to seizure, and hyperactivity. And it made mice’s…
The fragile X mental retardation protein plays a role in the development of the hearing system, a study in mice reports. This could explain why people with fragile X syndrome, which is caused by the loss of the FMRP protein, are hypersensitive to sound, researchers said. In normal circumstances, the FMR1…
In a new commentary by leaders in the field, the National Fragile X Foundation (NFXF) announced best practices for fragile X syndrome therapy development to improve the transition of treatments to human patients. The article, “Best Practices in Fragile X Syndrome Treatment Development,”…
Mice with the genetic defect that causes fragile X syndrome (FXS) are unable to learn new information that contradicts what they initially learned, researchers at NYU and the State University of New York report. The study, “Control of recollection by slow gamma dominating mid-frequency gamma…
This week marks the launch of the “7,000 Mile Rare Movement,” a nationwide effort to raise money for research into the 7,000 known rare diseases that afflict at least 30 million Americans. The campaign kicks off Feb. 1 and culminates with Rare Disease Day on Feb. 28. Organized by…
The intellectual disabilities in people with fragile X syndrome may be caused by poor communication between neurons, rather than flaws in the nerve cells, according to research from New York University. A research team there discovered that groups of neurons failed to signal in unison when mice with the…
Strategies to Promote Mindfulness, Acceptance Can Benefit Mothers of Fragile X Children, Study Shows
Interventions focused on improving mindfulness and acceptance may promote the health and well-being of mothers who have children with fragile X syndrome (FXS), as well as having important health implications for all individuals with an FMR1 premutation, a study finds. The study, “Mindfulness and Acceptance…
Children with the FMR1 premutation experience difficulties in processing sensory information, similar to those experienced by children with fragile x syndrome, a study shows. The study, “Sensory Difficulties in Children With an FMR1 Premutation,” was published in the journal Frontiers in Genetics. Fragile x syndrome (FXS) is caused…
Recent Posts
- 1st patient enrolled in Phase 2 trial of treatment for fragile X syndrome
- Phase 2 trial of experimental oral treatment enrolling fragile X males
- SPG601 calms brain activity in men with fragile X, helping them to focus
- Cannabidiol gel ZYN002 for fragile X fails to meet goal in clinical trial
- Fragile X, ASD children have distinct brain network patterns
- SPG601 granted orphan drug status in EU for treating fragile X
- Supporters getting ready for Fragile X Awareness Month
- Fragile X treatment KER-0193 gets FDA orphan, rare disease tags
- Long-term ZYN002 eases irritability in fragile X patients: Trial data
- Fragile X treatment KER-0193 found safe in healthy adults in trial